Althanoon Z, Faisal IM, Ahmad AA, Merkhan MM, Merkhan MM. Pharmacological aspects of statins are relevant to their structural and physicochemical properties. Syst Rev Pharm. 2020;11(7):167–71.

CAS  Google Scholar 

Niedzielski M, Broncel M, Gorzelak-Pabiś P, Woźniak E. New possible pharmacological targets for statins and ezetimibe. Biomed Pharmacother. 2020;129: 110388.

Article  CAS  PubMed  Google Scholar 

Miller BF, Thyfault JP. Exercise-pharmacology interactions: metformin, statins, and healthspan. Physiology. 2020;35(5):338–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahmadi Y, Ghorbanihaghjo A, Argani H. The effect of statins on the organs: similar or contradictory? J Cardiovasc Thorac Res. 2017;9(2):64–70.

Article  PubMed  PubMed Central  Google Scholar 

Bahrami A, Bo S, Jamialahmadi T, Sahebkar A. Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ageing: Molecular mechanisms. Ageing Res Rev. 2020;58: 101024.

Article  CAS  PubMed  Google Scholar 

Bahrami A, Parsamanesh N, Atkin SL, Banach M, Sahebkar A. Effect of statins on toll-like receptors: a new insight to pleiotropic effects. Pharmacol Res. 2018;135:230–8.

Article  CAS  PubMed  Google Scholar 

Kouhpeikar H, Delbari Z, Sathyapalan T, Simental-Mendia LE, Jamialahmadi T, Sahebkar A. The Effect of Statins through Mast Cells in the Pathophysiology of Atherosclerosis: a Review. Curr Atheroscler Rep. 2020;22(5):19.

Article  CAS  PubMed  Google Scholar 

Koushki K, Shahbaz SK, Mashayekhi K, Sadeghi M, Zayeri ZD, Taba MY, et al. Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and Toll-Like receptor pathways. Clin Rev Allergy Immunol. 2021;60(2):175–99.

Article  CAS  PubMed  Google Scholar 

Parizadeh SM, Azarpazhooh MR, Moohebati M, Nematy M, Ghayour-Mobarhan M, Tavallaie S, et al. Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial. Lipids. 2011;46(4):333–40.

Article  CAS  PubMed  Google Scholar 

Sahebkar A, Kotani K, Serban C, Ursoniu S, Mikhailidis DP, Jones SR, et al. Statin therapy reduces plasma endothelin-1 concentrations: a meta-analysis of 15 randomized controlled trials. Atherosclerosis. 2015;241(2):433–42.

Article  CAS  PubMed  Google Scholar 

Sahebkar A, Serban C, Mikhailidis DP, Undas A, Lip GY, Muntner P, et al. Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials. Thromb Haemost. 2015;114(3):546–57.

PubMed  Google Scholar 

Sahebkar A, Serban C, Ursoniu S, Mikhailidis DP, Undas A, Lip GY, et al. The impact of statin therapy on plasma levels of von Willebrand factor antigen. Systematic review and meta-analysis of randomised placebo-controlled trials. Thromb Haemost. 2016;115(3):520–32.

Article  PubMed  Google Scholar 

Serban C, Sahebkar A, Ursoniu S, Mikhailidis DP, Rizzo M, Lip GY, et al. A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations. Sci Rep. 2015;5:9902.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bland AR, Payne FM, Ashton JC, Jamialahmadi T, Sahebkar A. The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury. Pharmacol Res. 2022;175: 105986.

Article  CAS  PubMed  Google Scholar 

Mahjoubin-Tehran M, De Vincentis A, Mikhailidis DP, Atkin SL, Mantzoros CS, Jamialahmadi T, et al. Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis. Mol Metab. 2021;50: 101049.

Article  CAS  PubMed  Google Scholar 

Sahebkar A, Chew GT, Watts GF. Recent advances in pharmacotherapy for hypertriglyceridemia. Prog Lipid Res. 2014;56:47–66.

Article  CAS  PubMed  Google Scholar 

Shakour N, Ruscica M, Hadizadeh F, Cirtori C, Banach M, Jamialahmadi T, et al. Statins and C-reactive protein: in silico evidence on direct interaction. Arch Med Sci. 2020;16(6):1432–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sohrevardi SM, Nasab FS, Mirjalili MR, Bagherniya M, Tafti AD, Jarrahzadeh MH, et al. Effect of atorvastatin on delirium status of patients in the intensive care unit: a randomized controlled trial. Arch Med Sci. 2021;17(5):1423–8.

Article  CAS  PubMed  Google Scholar 

Di Bello E, Zwergel C, Mai A, Valente S. The innovative potential of statins in cancer: new targets for new therapies. Front Chem. 2020;8:516.

Article  PubMed  PubMed Central  Google Scholar 

Climent E, Benaiges D, Pedro-Botet J. Hydrophilic or lipophilic statins? Fron Cardiovasc Med. 2021;8:491.

Google Scholar 

Beckwitt CH, Shiraha K, Wells A. Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling. PLoS ONE. 2018;13(5): e0197422.

Article  PubMed  PubMed Central  Google Scholar 

Ahmadi Y, Mahmoudi N, Yousefi B, Karimian A. The effects of statins with a high hepatoselectivity rank on the extra-hepatic tissues. New Funct Stat Pharmacol Res. 2020;152: 104621.

CAS  Google Scholar 

Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005;45:89–118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Q, Liao JK. Pleiotropic effects of statins. Circ J. 2010;74(5):818–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004. https://doi.org/10.1161/01.CIR.0000131517.20177.5a.

Article  PubMed  Google Scholar 

Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the cardiovascular system. Circ Res. 2017;120(1):229–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kavalipati N, Shah J, Ramakrishan A, Vasnawala H. Pleiotropic effects of statins. Indian J Endocrinol Metab. 2015;19(5):554.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sadowitz B, Maier KG, Gahtan V. Basic science review: Statin therapy-Part I: the pleiotropic effects of statins in cardiovascular disease. Vasc Endovasc Surg. 2010;44(4):241–51.

Article  Google Scholar 

Bedi O, Dhawan V, Sharma P, Kumar P. Pleiotropic effects of statins: new therapeutic targets in drug design. Naunyn Schmiedebergs Arch Pharmacol. 2016;389(7):695–712.

Article  CAS  PubMed  Google Scholar 

Palaniswamy C, Selvaraj DR, Selvaraj T, Sukhija R. Mechanisms underlying pleiotropic effects of statins. Am J Ther. 2010;17(1):75–8.

Article  PubMed  Google Scholar 

McTaggart S. Isoprenylated proteins. Cell Mol Life Sci CMLS. 2006;63(3):255–67.

Article  CAS  PubMed  Google Scholar 

Jeong A, Suazo KF, Wood WG, Distefano MD, Li L. Isoprenoids and protein prenylation: implications in the pathogenesis and therapeutic intervention of Alzheimer’s disease. Crit Rev Biochem Mol Biol. 2018;53(3):279–310.

Article  PubMed  PubMed Central  Google Scholar 

Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer. 2003;3(1):11–22.

Article  CAS  PubMed  Google Scholar 

Macaluso M, Russo G, Cinti C, Bazan V, Gebbia N, Russo A. Ras family genes: an interesting link between cell cycle and cancer. J Cell Physiol. 2002;192(2):125–30.

Article  CAS  PubMed  Google Scholar 

Raghavaraju G, Liu H-S. Ha-ras Oncogene and Anticancer Drug Resistance. Genomic Med, Biomark, Health Sci. 2011;3(1):39–48.

Article  CAS  Google Scholar 

Wennerberg K, Rossman KL, Der CJ. The Ras superfamily at a glance. J Cell Sci. 2005;118(5):843–6.

Article  CAS  PubMed  Google Scholar 

Nussinov R, Tsai CJ, Jang H. Oncogenic Ras Isoforms Signaling Specificity at the Membrane. Cancer Res. 2018;78(3):593–602.

Article  CAS  PubMed  Google Scholar 

Stephen AG, Esposito D, Bagni RK, McCormick F. Dragging ras back in the ring. Cancer Cell. 2014;25(3):272–81.

Article  CAS  PubMed